和铂医药(02142.HK)与国药(01099.HK)战略合作 覆盖肿瘤及免疫炎症等疾病领域

阿斯达克财经
Jul 27

和铂医药(02142.HK) 与国药(01099.HK) 签署战略合作协议,以建立创新联合体,并就创新型生物药的研发领域开展合作,战略重点覆盖肿瘤及免疫炎症等疾病领域。双方将围绕创新型生物药的全生命周期开展研发合作,战略重点覆盖肿瘤及免疫炎症等疾病领域。集团将利用其全球领先的全人源抗体技术平台Harbour Mice及AI赋能研发能力,与国药集团共同开展候选抗体分子的发现与优化工作。国药集团还将...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10